Our Medicinal Chemistry team includes experts in computational methods to aid the compound development process.

Besides the traditional small molecule drugs and monoclonal antibodies, our services include the generation of proteolysis-targeting chimeras (PROTACs), DNA-encoded chemical libraries (DEL) and antibody-drug conjugates (ADC).

 

We strongly believe that inventive planning and methodologies improvement always complement the innovations. Attention to clients’ needs and the constant communication help us implement the projects efficiently and in time.